Megan S Jeon1, Haryana M Dhillon2, Joseph Descallar1,3, Lawrence Lam4, Samuel Allingham5, Eng-Siew Koh1,3, David C Currow4, Meera R Agar1,4,3. 1. South Western Sydney Clinical School, University of New South Wales, Australia. 2. Centre for Medical Psychology & Evidence-based Decision-making, University of Sydney, Australia. 3. Ingham Institute for Applied Medical Research, Sydney, Australia. 4. IMPACCT (Improving Palliative, Aged and Chronic Care through Clinical Research and Translation), Faculty of Health, University of Technology Sydney, Australia. 5. Palliative Care Outcomes Collaboration, University of Wollongong, Australia.
Abstract
BACKGROUND: The literature describing the incidence of sleep difficulty in CNS cancers is very limited, with exploration of a sleep difficulty symptom trajectory particularly sparse in people with advanced disease. We aimed to establish the prevalence and longitudinal trajectory of sleep difficulty in populations with CNS cancers receiving palliative care nationally, and to identify clinically modifiable predictors of sleep difficulty. METHODS: A consecutive cohort of 2406 patients with CNS cancers receiving palliative care from sites participating in the Australian national Palliative Care Outcomes Collaboration were evaluated longitudinally on patient-reported sleep difficulty from point-of-care data collection, comorbid symptoms, and clinician-rated problems. Multilevel models were used to analyze patient-reported sleep difficulty. RESULTS: Reporting of mild to severe sleep difficulties ranged from 10% to 43%. Sleep scores fluctuated greatly over the course of palliative care. While improvement in patients' clinical status was associated with less sleep difficulty, the relationship was not clear when patients deteriorated. Worsening of sleep difficulty was associated with higher psychological distress (P < .0001), greater breathing problems (P < .05) and pain (P < .05), and higher functional status (P < .001) at the beginning of care. CONCLUSIONS: Sleep difficulty is prevalent but fluctuates widely in patients with CNS cancers receiving palliative care. A better-tailored sleep symptom assessment may be needed for this patient population. Early interventions targeting psychological distress, breathing symptoms, and pain for more functional patients should be explored to see whether it reduces sleep difficulties late in life.
BACKGROUND: The literature describing the incidence of sleep difficulty in CNS cancers is very limited, with exploration of a sleep difficulty symptom trajectory particularly sparse in people with advanced disease. We aimed to establish the prevalence and longitudinal trajectory of sleep difficulty in populations with CNS cancers receiving palliative care nationally, and to identify clinically modifiable predictors of sleep difficulty. METHODS: A consecutive cohort of 2406 patients with CNS cancers receiving palliative care from sites participating in the Australian national Palliative Care Outcomes Collaboration were evaluated longitudinally on patient-reported sleep difficulty from point-of-care data collection, comorbid symptoms, and clinician-rated problems. Multilevel models were used to analyze patient-reported sleep difficulty. RESULTS: Reporting of mild to severe sleep difficulties ranged from 10% to 43%. Sleep scores fluctuated greatly over the course of palliative care. While improvement in patients' clinical status was associated with less sleep difficulty, the relationship was not clear when patients deteriorated. Worsening of sleep difficulty was associated with higher psychological distress (P < .0001), greater breathing problems (P < .05) and pain (P < .05), and higher functional status (P < .001) at the beginning of care. CONCLUSIONS: Sleep difficulty is prevalent but fluctuates widely in patients with CNS cancers receiving palliative care. A better-tailored sleep symptom assessment may be needed for this patient population. Early interventions targeting psychological distress, breathing symptoms, and pain for more functional patients should be explored to see whether it reduces sleep difficulties late in life.
Authors: Terri S Armstrong; Yuan Ying; Jimin Wu; Alvina A Acquaye; Elizabeth Vera-Bolanos; Mark R Gilbert; Paul D Brown; Janette Vardy; Caroline Chung Journal: Neuro Oncol Date: 2015-04-09 Impact factor: 12.300
Authors: Paul D Brown; Karla V Ballman; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Bradley F Boeve; Lalit Gupta; David F Tang-Wai; Robert M Arusell; Matthew M Clark; Jan C Buckner Journal: J Neurooncol Date: 2006-02 Impact factor: 4.130
Authors: D Howell; T K Oliver; S Keller-Olaman; J R Davidson; S Garland; C Samuels; J Savard; C Harris; M Aubin; K Olson; J Sussman; J MacFarlane; C Taylor Journal: Ann Oncol Date: 2013-11-27 Impact factor: 32.976
Authors: Bang-Ning Lee; Robert Dantzer; Keith E Langley; Gary J Bennett; Patrick M Dougherty; Adrian J Dunn; Christina A Meyers; Andrew H Miller; Richard Payne; James M Reuben; Xin Shelley Wang; Charles S Cleeland Journal: Neuroimmunomodulation Date: 2004 Impact factor: 2.492
Authors: Laura Q Rogers; Kerry S Courneya; K Thomas Robbins; Krishna Rao; James Malone; Alison Seiz; Sheryl Reminger; Stephen J Markwell; Vishal Burra Journal: Head Neck Date: 2008-10 Impact factor: 3.147
Authors: Jane Gibbins; Rachel McCoubrie; Adrian H Kendrick; Gaye Senior-Smith; Andrew N Davies; Geoffrey W Hanks Journal: J Pain Symptom Manage Date: 2009-12 Impact factor: 3.612
Authors: David C Currow; Samuel Allingham; Patsy Yates; Claire Johnson; Katherine Clark; Kathy Eagar Journal: Support Care Cancer Date: 2014-07-27 Impact factor: 3.603
Authors: Megan S Jeon; Meera R Agar; Eng-Siew Koh; Anna K Nowak; Elizabeth J Hovey; Haryana M Dhillon Journal: Support Care Cancer Date: 2021-01-02 Impact factor: 3.603
Authors: Megan S Jeon; Haryana M Dhillon; Eng-Siew Koh; Anna K Nowak; Elizabeth Hovey; Joseph Descallar; Lisa Miller; Nathaniel S Marshall; Meera R Agar Journal: Neurooncol Pract Date: 2020-09-12
Authors: Mirjam Renovanz; Anne-Katrin Hickmann; Minou Nadji-Ohl; Naureen Keric; Elke Weimann; Christian Rainer Wirtz; Susanne Singer; Florian Ringel; Jan Coburger Journal: Support Care Cancer Date: 2020-02-14 Impact factor: 3.603